Compare MITK & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITK | BWAY |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.1M | 450.8M |
| IPO Year | 1995 | N/A |
| Metric | MITK | BWAY |
|---|---|---|
| Price | $14.57 | $23.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $15.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 992.5K | 81.4K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.43 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $45,390,000.00 | N/A |
| Revenue This Year | $9.55 | $314.08 |
| Revenue Next Year | $7.15 | $23.37 |
| P/E Ratio | $245.67 | ★ $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.93 | $7.84 |
| 52 Week High | $15.15 | $26.63 |
| Indicator | MITK | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 70.56 | 50.89 |
| Support Level | $9.30 | $14.79 |
| Resistance Level | N/A | $25.71 |
| Average True Range (ATR) | 0.64 | 1.35 |
| MACD | 0.23 | -0.12 |
| Stochastic Oscillator | 85.07 | 38.47 |
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.